focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,787.50
Bid: 1,787.00
Ask: 1,787.50
Change: -25.00 (-1.38%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,785.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Consumer Confidence Hits Nine-Year High

Fri, 30th May 2014 10:28

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Polymer products manufacturer Fenner PLC said underlying pretax profit for the year will be 10% to 15% below the prevailing market consensus forecast of GBP77.6 million, as trading conditions in the US continue to deteriorate while its Australian arm suffered a setback following the loss of a profitable contract. In the year ended August 31, 2013, Fenner's pretax profit was GBP67.9 million, down from GBP86.6 million a year earlier. The company, which reported a fall in profit and revenue for the first half earlier this year, said trading conditions in the US have shown no sign of imminent improvement, while the coal industry remains cautious. It therefore expects its Engineered Conveyor Solutions arm to report significantly weaker results in the US than previously expected for the rest of the financial year.
----------
P2P Global Investments PLC will start trading on the London Stock Exchange's main market after its initial public offering, while Clipper Logistics PLC has priced its IPO at 100 pence a share, meaning it will raise about GBP100 million. P2P closed its placing and intermediaries offer on Wednesday, ahead of its admission. It had offered 20 million shares at 1,000 pence a share, meaning it will have an initial market capitalisation of GBP200 million. The company will invest in online and peer-to-peer lending, a small, but fast-growing part of the global financial system. Retail logistics company Clipper, meanwhile, said it will place 49.9 million shares in its IPO, with conditional dealings also starting. It will have 100 million shares in issue in total.
----------
GlaxoSmithKline PLC has invited private equity firms to bid for some of its older drugs in the latest step by Chief Executive Andrew Witty to reshape the UK’s biggest drugmaker, the Financial Times reports, citing people familiar with the situation. Private equity companies including Advent International, Blackstone and KKR are among those to have been alerted to the opportunity, The FT quoted the people as saying.
----------
Unite Group PLC said it has agreed to acquire and redevelop a 0.77 acre site from Portsmouth City Council, which subject to planning permission will be turned into a 830 bed student halls of residence. The financial terms of the deal have not been disclosed. Student accommodation provider Unite said the site which is located in Portsmouth's city centre should be completed in time for the 2016/17 academic year if planning permission is granted.
----------
MARKETS
----------
UK stocks trade mixed, with the FTSE 100 struggling to add to its recent strong gains, as it is weighed down by some of its mining constituents.
----------
FTSE 100: down 0.1% at 6864.41
FTSE 250: up 0.4% at 16011.62
AIM ALL-SHARE: down 0.1% at 810.56
----------
The pound has hit a two-day high against the dollar as a consumer sentiment index indicates that Britons have become more optimistic over nation's recovery.
----------
GBP-USD: up at USD1.6735
EUR-USD: up at USD1.3613

GOLD: down at USD1254.79 per ounce
OIL (Brent): down at USD109.84 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
An index measuring consumer sentiment in the UK came in with a score of 0 in May, polling company GfK said. That beat forecasts for a score of -2 and was up from -3 in April. The May reading represents a nine-year high score for the index. All the five sub-indicators, used to calculate the total index, witnessed growth in May.
----------
Germany's retail sales fell unexpectedly in April after rising for three consecutive months, official figures revealed. Retail sales turnover declined by a real 0.9% from March, when it was up 0.1%, Destatis reported. Sales were expected to rise by 0.2%. Meanwhile, on a yearly basis, retail sales grew 3.4%, reversing the 1.1% drop in March. The rate also exceeded 1.5% rise expected by economists.
----------
Italy's harmonized consumer price inflation slowed unexpectedly in May, preliminary estimate from the statistical office Istat showed. The harmonized index of consumer prices rose 0.4% year-on-year in May, slightly slower than the 0.5% increase posted in April. The rate was expected to remain at 0.5%. Similarly, consumer price inflation eased marginally to 0.5% from 0.6% a month ago. Prices were forecast to rise by 0.6%.
----------
Industrial output in Japan dipped 2.5% on month in April, the Ministry of Economy, Trade and Industry said. That missed forecasts for a decline of 2.0% following the 0.7% increase in March. On a yearly basis, industrial production added 4.1% - also missing expectations for 4.5% and down from 7.4% in the previous month.
----------
Nationwide core inflation in Japan was up 3.2% on year in April, the Ministry of Internal Affairs and Communications said. That topped forecasts for 3.1% and was up sharply from 1.3% in March. Overall nationwide CPI climbed 3.4% - in line with expectations and up from 1.6% in the previous month. Meanwhile, the same government ministry said average of household spending in Japan was down 4.6% on year in April, standing at 302,141. That missed forecasts for a decline of 3.4% following the 7.2% jump in March. It also said the unemployment rate in Japan was a seasonally adjusted 3.6% in April, unchanged from the previous month and in line with expectations.
----------
Four civilian observers from the Organization for Security and Co-operation in Europe held captive by pro-Russian militiamen in eastern Ukraine have been freed, separatist leader Alexei Chmilenko told Interfax. However, there was no official confirmation from the OSCE. Chmilenko, a leader of the self-proclaimed Luhansk People's Republic, said the incident was a warning to outsiders that they should not enter the area without prior notification, the Interfax news agency reported.
The Thai military junta is to send representatives to social media companies to ask them for access to chatrooms and groups that are deemed harmful to national security, reports said Friday.
----------
Facebook, Twitter, Google and popular instant messaging application Line are companies which the junta plans to talk to, a representative from Thailand's Ministry of Information and Communication Technology told Matichon Newspaper. The military government is asking for cooperation from the companies in taking down posts that are "sensitive" in the current political situation as well as group chats which might contain information deemed vital in protecting the nation.
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.